GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ovoca Bio PLC (DUB:OVXA) » Definitions » Purchase Of Business

Ovoca Bio (DUB:OVXA) Purchase Of Business : €0.00 Mil (TTM As of Jun. 2023)


View and export this data going back to 2010. Start your Free Trial

What is Ovoca Bio Purchase Of Business?

Ovoca Bio's purchase of business for the six months ended in Jun. 2023 was €0.00 Mil. It means Ovoca Bio spent €0.00 Mil on purchasing business. Ovoca Bio's purchase of business for the trailing twelve months (TTM) ended in Jun. 2023 was €0.00 Mil.

Compared with last quarter (€0.00 Mil in Dec. 2022 ), Ovoca Bio spent the same money on purchasing business in Jun. 2023 (€0.00 Mil).

Ovoca Bio Purchase Of Business Historical Data

The historical data trend for Ovoca Bio's Purchase Of Business can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ovoca Bio Purchase Of Business Chart

Ovoca Bio Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Purchase Of Business
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.48 - - - -

Ovoca Bio Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Purchase Of Business Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Ovoca Bio Purchase Of Business Calculation

The amount used to purchase business.

Purchase Of Business for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ovoca Bio Purchase Of Business Related Terms

Thank you for viewing the detailed overview of Ovoca Bio's Purchase Of Business provided by GuruFocus.com. Please click on the following links to see related term pages.

Ovoca Bio (DUB:OVXA) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ovoca Bio PLC (DUB:OVXA) » Definitions » Purchase Of Business
Comparable Companies
LSE:BMS LSE:MSI LSE:GATC LSE:SNR LSE:IOM LSE:CLBS LSE:SXS LSE:PALM LSE:MTC LSE:FRES OCSE:NOVO B VRTX REGN ASX:CSL MRNA XKRX:207940 XKRX:068270 XBRU:UCB BNTX XBRU:ARGX
Traded in Other Exchanges
OVB.GB:UK OVB:UK OVXA:Germany
Address
17 Pembroke Street Upper, Dublin, IRL, D02 AT22
Website
https://www.ovocabio.com
Ovoca Bio PLC is a life science investment company. The company is engaged in investing in the development and commercialization of novel product candidates for the treatment of female sexual dysfunctions. The group has two business segments, bio-pharmaceutical and investment, which are operated principally in Russian Federation and investment activities operated from Bermuda, and with administrative activities in the Republic of Ireland. Its product candidate includes IVIX - Libicore - a novel synthetic peptide, administrated through a nasal spray.

Ovoca Bio (DUB:OVXA) Headlines

No Headlines